Role of Leptin in the Association Between Body Adiposity and Persistent Asthma: A Longitudinal Study.


Journal

Obesity (Silver Spring, Md.)
ISSN: 1930-739X
Titre abrégé: Obesity (Silver Spring)
Pays: United States
ID NLM: 101264860

Informations de publication

Date de publication:
06 2019
Historique:
received: 01 06 2018
accepted: 24 02 2019
pubmed: 21 4 2019
medline: 12 3 2020
entrez: 21 4 2019
Statut: ppublish

Résumé

Obesity is a likely risk factor for asthma. However, underlying mechanisms by which obesity affects asthma activity remain poorly understood. This study aimed to investigate the role of leptin, an adipocyte-derived proinflammatory protein, as a mediator in the association between body adiposity (assessed using BMI, waist circumference, and body fat percentage) and persistent asthma. A causal approach to mediation analysis was used to disentangle total and direct effects and the indirect effect mediated by leptin, using data from the French prospective French Epidemiological Study on the Genetics and Environment of Asthma (EGEA) (baseline: 2003-2007; follow-up: 2011-2013; mean follow-up time: 7 years). A total of 331 participants with current asthma at baseline were included. Per 1-SD increment in BMI, waist circumference, and body fat percentage, the adjusted odds ratios of the total effect were 1.59 (95% CI: 0.95-2.97), 2.06 (1.06-4.00), and 3.25 (1.01-9.41), respectively; the odds ratios of the indirect effect mediated by leptin were 1.68 (1.09-2.46), 1.55 (0.99-2.57), and 1.99 (0.94-4.83), respectively. Leptin partly (> 60%) mediated the association between high body adiposity and persistent asthma over time. Using a newly developed analytic approach, this longitudinal study brought new insight into one mechanism by which obesity may affect asthma activity.

Identifiants

pubmed: 31004416
doi: 10.1002/oby.22466
doi:

Substances chimiques

Leptin 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

894-898

Subventions

Organisme : NIDDK NIH HHS
ID : U24 DK059637
Pays : United States

Informations de copyright

© 2019 The Obesity Society.

Auteurs

Zhen Li (Z)

VIMA: Aging and Chronic Diseases, Epidemiological and Public Health Approaches, INSERM U1168, Villejuif, France.
UMR-S 1168, University of Versailles St-Quentin-en-Yvelines, Montigny le Bretonneux, France.
Ministry of Education Key Laboratory of Obstetric, Gynecologic & Pediatric Diseases and Birth Defects, West China Second University Hospital, Sichuan University, Chengdu, Sichuan, China.

Bénédicte Leynaert (B)

Pathophysiology and Epidemiology of Respiratory Diseases, INSERM UMR1152, Paris Diderot University, Paris, France.

Orianne Dumas (O)

VIMA: Aging and Chronic Diseases, Epidemiological and Public Health Approaches, INSERM U1168, Villejuif, France.
UMR-S 1168, University of Versailles St-Quentin-en-Yvelines, Montigny le Bretonneux, France.

Oscar Diaz Gil (O)

Cardiovascular Risk and Nutrition (Regicor Study Group), Hospital del Mar Research Institute (IMIM), Barcelona, Spain.
CIBER de Fisiopatología de la Obesidad y Nutrición (CIBEROBN), Institute of Health Carlos III, Madrid, Spain.

Judith Garcia-Aymerich (J)

ISGlobal, Centre for Research in Environmental Epidemiology (CREAL), Barcelona, Spain.
Universitat Pompeu Fabra (UPF), Barcelona, Spain.
CIBER Epidemiología y Salud Pública (CIBERESP), Barcelona, Spain.

Montserrat Fito Colomer (M)

Cardiovascular Risk and Nutrition (Regicor Study Group), Hospital del Mar Research Institute (IMIM), Barcelona, Spain.
CIBER de Fisiopatología de la Obesidad y Nutrición (CIBEROBN), Institute of Health Carlos III, Madrid, Spain.

Nicole Le Moual (N)

VIMA: Aging and Chronic Diseases, Epidemiological and Public Health Approaches, INSERM U1168, Villejuif, France.
UMR-S 1168, University of Versailles St-Quentin-en-Yvelines, Montigny le Bretonneux, France.

Christophe Pison (C)

Clinique Universitaire de Pneumologie, CHU Grenoble Alpes, Pôle Thorax et Vaisseaux, INSERM 1055, Grenoble, France.

Isabelle Romieu (I)

Instituto Nacional De Salud Publica, Mexico.

Valérie Siroux (V)

Team of Environmental Epidemiology Applied to Reproduction and Respiratory Health, Institute for Advanced Bioscience, INSERM, Grenoble, France.
Team of Environmental Epidemiology Applied to Reproduction and Respiratory Health, University of Grenoble Alpes, IAB, Grenoble, France.
Team of Environmental Epidemiology Applied to Reproduction and Respiratory Health, CHU Grenoble Alpes, Institute for Advanced Bioscience, Grenoble, France.

Carlos A Camargo (CA)

Department of Emergency Medicine, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA.

Raphaëlle Varraso (R)

VIMA: Aging and Chronic Diseases, Epidemiological and Public Health Approaches, INSERM U1168, Villejuif, France.
UMR-S 1168, University of Versailles St-Quentin-en-Yvelines, Montigny le Bretonneux, France.

Rachel Nadif (R)

VIMA: Aging and Chronic Diseases, Epidemiological and Public Health Approaches, INSERM U1168, Villejuif, France.
UMR-S 1168, University of Versailles St-Quentin-en-Yvelines, Montigny le Bretonneux, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH